drugset / Trial / NCT00083538

Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally

NCT00083538

Phase 2 Completed 40 enrolled University of Arkansas
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if vaccination with autologous idiotype- or tumor lysate-pulsed dendritic cells induces the generation of anti-idiotypic and anti-tumor immunologic responses.

Timeline

Start
2001-02
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Background Cisplatin Other / unclassified
Background Cyclophosphamide Other / unclassified
Background Dexamethasone Small molecule
Background Doxorubicin Other / unclassified
Background Etoposide Small molecule
Background Thalidomide Other / unclassified

Indications